Fangzhou Inc

Fangzhou Inc maintains a strong liquidity position with cash and equivalents amounting to CNY 233.49 million, which is 35.3% of total assets. The company's liquidity FPT (Fundamental Price-to-Tangible Book) is 8.02, indicating a premium valuation relative to its tangible book value. The current ratio of 1.2 suggests the company can cover its short-term liabilities with its current assets, though not with a large margin of safety. Profitability metrics show a return on equity (ROE) of 7.7%, which is modest but positive, and a return on assets (ROA) of 1.45%, indicating that the company is generating relatively low returns on its asset base. The gross profit margin is 15.87%, and the operating margin is 0.38%, both of which are below the industry median for drug retailers, suggesting potential inefficiencies in cost management or pricing power. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic fluctuations and regulatory changes. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk distribution. Fangzhou Inc's revenue growth trajectory is not clearly defined in the provided data, as historical revenue figures are not available. However, the company's current revenue of CNY 3.53 billion suggests a stable base, and the outlook for the current fiscal year is neutral with no significant growth or contraction expected. The next fiscal year is also projected to remain stable, with no material changes in revenue anticipated. The risk assessment indicates low liquidity and dilution risks, with no immediate filing-based flags detected. The debt-to-equity ratio of 0.23 suggests a conservative capital structure, and the company has not issued additional shares recently. The absence of dilution potential and manageable debt levels contribute to a stable financial profile. Recent events and filings do not show any material changes or significant corporate actions that would impact the company's financial position. The company's financial statements and disclosures are consistent with a stable and transparent business model, with no notable risks or opportunities highlighted in the latest filings.